Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,616,399 | 1,282,963 | 5,400,601 | 3,578,038 | 1,679,474 |
| Depreciation Amortization | 2,518,686 | 1,540,858 | 2,477,389 | 1,523,207 | 915,953 |
| Accounts receivable | N/A | N/A | -572,629 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 174,859 | N/A | N/A |
| Other Working Capital | -2,048,120 | -2,031,900 | 4,651,778 | 1,314,727 | 1,279,340 |
| Other Operating Activity | -448,709 | 71,637 | -891,648 | -810,466 | -846,542 |
| Operating Cash Flow | $2,638,256 | $863,558 | $11,240,350 | $5,605,506 | $3,028,225 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,857 | 7,815 | -210,898 | -274,933 | 55,801 |
| PPE Investments | -554,137 | -280,038 | -1,569,725 | -1,005,916 | -706,359 |
| Net Acquisitions | -4,665,806 | -4,773,663 | 38,709 | 33,878 | 34,025 |
| Purchase Of Investment | -6,429 | -5,210 | -13,348 | N/A | N/A |
| Purchase Sale Intangibles | -547,708 | -96,385 | -261,621 | -200,662 | -225,926 |
| Other Investing Activity | -566,993 | -96,385 | -317,682 | -238,449 | -244,980 |
| Investing Cash Flow | $-5,806,221 | $-5,147,480 | $-2,072,944 | $-1,485,420 | $-861,513 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,327,754 | 7,438,578 | 108,119 | 16,939 | 609,728 |
| Debt Issued | 3,346,677 | 3,415,155 | 13,532,200 | 13,147,270 | 13,675,330 |
| Common Stock Issued | 42,428 | 35,168 | 98,775 | 40,393 | 31,303 |
| Dividend Paid | -2,663,970 | -1,217,838 | -5,241,760 | -3,899,879 | -2,802,299 |
| Other Financing Activity | -6,492,786 | -4,902,610 | -17,025,371 | -13,400,052 | -13,518,815 |
| Financing Cash Flow | $3,560,103 | $4,768,453 | $-8,528,037 | $-4,095,329 | $-2,004,753 |
| Exchange Rate Effect | 18,000 | -52,100 | 10,678 | -41,696 | -46,274 |
| Beginning Cash Position | 5,254,656 | 5,323,317 | 4,805,280 | 4,690,800 | 4,899,600 |
| End Cash Position | 5,664,794 | 5,755,748 | 5,455,328 | 4,673,861 | 5,015,285 |
| Net Cash Flow | $410,138 | $432,430 | $650,048 | $-16,939 | $115,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,638,256 | 863,558 | 11,240,350 | 5,605,506 | 3,028,225 |
| Capital Expenditure | -644,136 | -289,155 | -1,793,971 | -1,097,126 | -736,301 |
| Free Cash Flow | 1,994,120 | 574,403 | 9,446,379 | 4,508,380 | 2,291,924 |